US Stock MarketDetailed Quotes
CHRO Channel Therapeutics
- 0.630
- -0.001-0.16%
Close Nov 18 16:00 ET
3.80MMarket Cap-364P/E (TTM)
0.690High0.626Low14.74KVolume0.690Open0.631Pre Close9.60KTurnover0.93%Turnover RatioLossP/E (Static)6.03MShares6.00052wk High-2.66P/B999.86KFloat Cap0.52052wk Low--Dividend TTM1.59MShs Float6.000Historical High--Div YieldTTM10.22%Amplitude0.520Historical Low0.651Avg Price1Lot Size
Channel Therapeutics Stock Forum
Sign in to post a comment
$Homestolife (HTLM.US)$ $Protagenic Therapeutics (PTIX.US)$ $Conifer Holdings (CNFR.US)$ $Kazia Therapeutics (KZIA.US)$ $ZHONGCHAO (ZCMD.US)$ $Channel Therapeutics (CHRO.US)$ $AgEagle Aerial Systems (UAVS.US)$ $Pasithea Therapeutics (KTTA.US)$ $Golden Sun Health Technology (GSUN.US)$ $Vast Renewables (VSTE.US)$ $American Rebel (AREB.US)$ $Lixte Biotechnology (LIXT.US)$ $Innovative Eyewear (LUCY.US)$ $Shuttle Pharmaceuticals (SHPH.US)$
📊⚡️📊
📊⚡️📊
5
12
$Channel Therapeutics (CHRO.US)$ Chromocell Unveils Its Injectable Depot Program Utilizing Peripheral Nerve Blocks For The Treatment Of Post-Operative Pain
Benzinga· 2 mins ago
Benzinga· 2 mins ago
1
$Channel Therapeutics (CHRO.US)$
Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain
Chromocell Therapeutics (NYSE American: CHRO) has unveiled an injectable depot program using peripheral nerve blocks for post-operative pain treatment. The program leverages the company's NaV1.7 molecule, targeting a market of approximately 700,000 total knee replacements and 500,000 shoulder arthroplastiesperformed annually in the US. The company's drug has shown...
Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain
Chromocell Therapeutics (NYSE American: CHRO) has unveiled an injectable depot program using peripheral nerve blocks for post-operative pain treatment. The program leverages the company's NaV1.7 molecule, targeting a market of approximately 700,000 total knee replacements and 500,000 shoulder arthroplastiesperformed annually in the US. The company's drug has shown...
$Channel Therapeutics (CHRO.US)$
looking good for a decent run maybe 🤞
looking good for a decent run maybe 🤞
1
$Channel Therapeutics (CHRO.US)$
something brewing here maybe?
something brewing here maybe?
$Channel Therapeutics (CHRO.US)$ weird.. stick with CTCX and STEC
$Channel Therapeutics (CHRO.US)$ $Big Tree Cloud (DSY.US)$ $Nuburu (BURU.US)$ $Pluri Inc (PLUR.US)$ $TFF Pharmaceuticals (TFFP.US)$ $Globavend Holdings (GVH.US)$ $CCSC Technology International (CCTG.US)$ $NanoVibronix (NAOV.US)$ $Vision Marine Technologies (VMAR.US)$ $Bright Minds Biosciences (DRUG.US)$ $Direct Digital (DRCT.US)$ $Expion360 (XPON.US)$
3
1
$The Real Good Food (RGF.US)$ $Onconetix (ONCO.US)$ $Cardio Diagnostics (CDIO.US)$ $Establishment Labs (ESTA.US)$ $Jianzhi Education (JZ.US)$ $ATIF Holdings (ATIF.US)$ $CN Energy (CNEY.US)$ $ZW Data Action Tech (CNET.US)$ $LakeShore Biopharma (LSB.US)$ $Channel Therapeutics (CHRO.US)$ $Pulmatrix (PULM.US)$ $Hyzon Motors (HYZN.US)$
4
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
EZ_money : i think i just pissed off Kevin
with the color comment... hey, you can add target to the list too
besides target, has any of those woke businesses truly rebound yet? i just assumed everyone knew about it
EZ_money : now i wonder
that mustache 
devils advocate here 
HailTheApocalypse EZ_money : damn the Woke!
EZ_money HailTheApocalypse : I'm fine with what people choose they do. i am no judgement, I'm not okay with changing or normalizing things that majority of the population don't believe in to satisfy a small tiny percentage of people compared to the rest of the world that doesn't agree with their views. I'm just trying to keep it real
and the woke companies as an investor haven't been the best. Target did bounce back nicely but they also offer that beautiful dividend
HailTheApocalypse EZ_money : I don't judge folks either. to each their own. but yea, all this changing this or that just to satisfy some folks has gotten out of hand and I don't really care for it.
View more comments...